1. Home
  2. AMBO vs PPBT Comparison

AMBO vs PPBT Comparison

Compare AMBO & PPBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambow Education Holding Ltd.

AMBO

Ambow Education Holding Ltd.

HOLD

Current Price

$2.18

Market Cap

7.2M

Sector

Real Estate

ML Signal

HOLD

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

HOLD

Current Price

$4.25

Market Cap

3.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBO
PPBT
Founded
2000
2010
Country
United States
Israel
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2M
3.8M
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
AMBO
PPBT
Price
$2.18
$4.25
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
9.8K
8.4K
Earning Date
08-05-2025
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
337.04
N/A
EPS
0.02
N/A
Revenue
$9,469,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$93.22
N/A
Revenue Growth
0.82
N/A
52 Week Low
$1.47
$0.41
52 Week High
$6.75
$5.18

Technical Indicators

Market Signals
Indicator
AMBO
PPBT
Relative Strength Index (RSI) 52.22 64.09
Support Level $1.72 $3.63
Resistance Level $2.37 $5.18
Average True Range (ATR) 0.22 0.32
MACD 0.04 -0.09
Stochastic Oscillator 55.42 79.74

Price Performance

Historical Comparison
AMBO
PPBT

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

Share on Social Networks: